Cargando…

Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience

Detalles Bibliográficos
Autores principales: Gangat, Naseema, Oliveira, Jennifer L., Porter, Tavanna R, Hoyer, James D., Al-Kali, Aref, Patnaik, Mrinal M, Pardanani, Animesh, Tefferi, Ayalew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052925/
https://www.ncbi.nlm.nih.gov/pubmed/35142155
http://dx.doi.org/10.3324/haematol.2021.280516
_version_ 1784696887139368960
author Gangat, Naseema
Oliveira, Jennifer L.
Porter, Tavanna R
Hoyer, James D.
Al-Kali, Aref
Patnaik, Mrinal M
Pardanani, Animesh
Tefferi, Ayalew
author_facet Gangat, Naseema
Oliveira, Jennifer L.
Porter, Tavanna R
Hoyer, James D.
Al-Kali, Aref
Patnaik, Mrinal M
Pardanani, Animesh
Tefferi, Ayalew
author_sort Gangat, Naseema
collection PubMed
description
format Online
Article
Text
id pubmed-9052925
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-90529252022-05-13 Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience Gangat, Naseema Oliveira, Jennifer L. Porter, Tavanna R Hoyer, James D. Al-Kali, Aref Patnaik, Mrinal M Pardanani, Animesh Tefferi, Ayalew Haematologica Letters to the Editor Fondazione Ferrata Storti 2022-02-10 /pmc/articles/PMC9052925/ /pubmed/35142155 http://dx.doi.org/10.3324/haematol.2021.280516 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Gangat, Naseema
Oliveira, Jennifer L.
Porter, Tavanna R
Hoyer, James D.
Al-Kali, Aref
Patnaik, Mrinal M
Pardanani, Animesh
Tefferi, Ayalew
Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
title Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
title_full Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
title_fullStr Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
title_full_unstemmed Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
title_short Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: the Mayo Clinic experience
title_sort erythrocytosis associated with epas1(hif2a), egln1(phd2), vhl, epor or bpgm mutations: the mayo clinic experience
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052925/
https://www.ncbi.nlm.nih.gov/pubmed/35142155
http://dx.doi.org/10.3324/haematol.2021.280516
work_keys_str_mv AT gangatnaseema erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT oliveirajenniferl erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT portertavannar erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT hoyerjamesd erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT alkaliaref erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT patnaikmrinalm erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT pardananianimesh erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience
AT tefferiayalew erythrocytosisassociatedwithepas1hif2aegln1phd2vhlepororbpgmmutationsthemayoclinicexperience